Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chunyan Chen
Observed names:
C Y CHEN,
Chun-Yan Chen
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Chinese Academy of Sciences,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0000-0002-6250-4226
Observed ORCID:
0000-0002-6250-4226
OpenAlex ID:
A5037360129
Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy Alone
2010
·
Sheng-Fa Su
, Fei Han
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
228
PDF
A new prognostic histopathologic classification of nasopharyngeal carcinoma
2016
·
Hai-Yun Wang
, Yih-Leong Chang
, et al.
·
癌症:英文版
·
148
PDF
Prognostic Value of Cervical Nodal Necrosis in Nasopharyngeal Carcinoma: Analysis of 1800 Patients with Positive Cervical Nodal Metastasis at MR Imaging
2015
·
Mei Lan
, Ying Huang
, et al.
·
Radiology
·
113
Treatment Outcomes After Radiotherapy Alone for Patients With Early-Stage Nasopharyngeal Carcinoma
2009
·
Wei-Wei Xiao
, Fei Han
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
106
Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
2011
·
Sheng-Fa Su
, Fei Han
, et al.
·
癌症:英文版
·
82
PDF
Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy
2013
·
Sheng-Fa Su
, Shao-Ming Huang
, et al.
·
Radiation Oncology
·
51
PDF
Clinical features of 337 patients with recurrent nasopharyngeal carcinoma
2010
·
Jia-Xin Li
, Tai-Xiang Lu
, et al.
·
癌症:英文版
·
41
Prognostic Value of Cervical Nodal Necrosis in Nasopharyngeal Carcinoma: Analysis of 1800 Patients with Positive Cervical Nodal Metastasis at MR Imaging
2015
·
Mei Lan
, Ying Huang
, et al.
·
Radiology
·
36
Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone
2009
·
C Y CHEN
, F HAN
, et al.
·
British Journal of Radiology
·
35
Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: Clinical outcomes and patterns of failure in an endemic area in China
2014
·
Lei Zeng
, Yun-Ming Tian
, et al.
·
Strahlentherapie und Onkologie
·
24
Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma
2013
·
Lei Zeng
, Xue-Ming Sun
, et al.
·
Head & Neck
·
24
Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
2025
·
Fei Cao
, Yan Li
, et al.
·
Clinical Cancer Research
·
10
Anti-programmed death-1 inhibitors and nimotuzumab in combination with induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
2025
·
Ya-Ni Zhang
, Yu-Pei Chen
, et al.
·
Therapeutic Advances in Medical Oncology
·
7
Concurrent chemotherapy using taxane plus cisplatin versus cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy
2023
·
Ya-Ni Zhang
, Yu-Pei Chen
, et al.
·
Therapeutic Advances in Medical Oncology
·
4
PDF
Supplement 4 from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
2025
·
Fei Cao
, Yan Li
, et al.
Data from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
2025
·
Fei Cao
, Yan Li
, et al.
Supplement 2 from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
2025
·
Fei Cao
, Yan Li
, et al.
Supplement 5 from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
2025
·
Fei Cao
, Yan Li
, et al.
Supplement 1 from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
2025
·
Fei Cao
, Yan Li
, et al.
Supplement 3 from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
2025
·
Fei Cao
, Yan Li
, et al.
Show more works
View as search
Works count:
20
Citation count:
909
H-index:
11
I10-index:
12
Year
Topic
Type